Ticker Launch
Sign inTry it free

Reverse merger · Completed · HCIL

Hong Chang Global Investment Holdings Limited (Hongchang BVI)

Reverse merger with Heyu Biological Technology Corporation

Hong Chang Global Investment Holdings Limited (Hongchang BVI) merged into Heyu Biological Technology Corporation, a OTC-listed company with a 60% stake in Shanghai Kangzi Medical Technology, disposed of at the transaction, in a reverse merger that takes the private company public. The deal was announced on Aug 21, 2023 and closed on Sep 7, 2023. The combined company trades as Hongchang International Co., Ltd (HCIL) on OTC.

Hongchang International builds and operates the Hongchang Food Industrial Park project in Fuqing, Fujian Province, China, through its subsidiary Fuqing Hongchang Food Co., Ltd., a key provincial project located in the Fuzhou New District.

Status
Completed
Private company
Hong Chang Global Investment Holdings Limited (Hongchang BVI)
Public company
Heyu Biological Technology Corporation
Public company business before
OTC-listed company with a 60% stake in Shanghai Kangzi Medical Technology, disposed of at the transaction
Announced
Aug 21, 2023
Closed
Sep 7, 2023
Combined company
Hongchang International Co., Ltd (HCIL)
Exchange
OTC
Sector
Industrials

More on this deal for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other completed reverse mergers